Histamine

potassium calcium-activated channel subfamily M regulatory beta subunit 2 ; Homo sapiens







26 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 26074818 Identification of amino acids involved in histamine potentiation of GABA A receptors. 2015 5
2 24900851 Discovery of AZD3199, An Inhaled Ultralong Acting β2 Receptor Agonist with Rapid Onset of Action. 2014 Apr 10 1
3 17196553 Histamine augments beta2-adrenoceptor-induced cyclic AMP accumulation in human prostate cancer cells DU-145 independently of known histamine receptors. 2007 Mar 15 1
4 16172269 Targeting adhesion molecules as a potential mechanism of action for intravenous immunoglobulin. 2005 Sep 27 1
5 11908511 Is the increase in bronchial responsiveness or FEV1 shortly after cessation of beta2-agonists reflecting a real deterioration of the disease in allergic asthmatic patients? A comparison between short-acting and long-acting beta2-agonists. 2002 Mar 2
6 11998988 Dose-related effects of formoterol on airway responsiveness to adenosine 5'-monophosphate and histamine. 2002 Apr 1
7 11549530 Inhaled corticosteroids, combined with long-acting beta(2)-agonists, improve the perception of bronchoconstriction in asthma. 2001 Sep 1 2
8 10351919 Differential effect of formoterol on adenosine monophosphate and histamine reactivity in asthma. 1999 Jun 1
9 10378545 Effects of a beta2-agonist on airway hyperreactivity in subjects with cervical spinal cord injury. 1999 Jun 1
10 10563469 The effect of salmeterol and salbutamol on mediator release and skin responses in immediate and late phase allergic cutaneous reactions. 1999 Oct 1
11 9569243 Histamine affects interleukin-4, interleukin-5, and interferon-gamma production by human T cell clones from the airways and blood. 1998 May 1
12 9438493 Anti-inflammatory effect of beta 2-agonists: inhibition of TNF-alpha release from human mast cells. 1997 Dec 1
13 8837662 Ex vivo pharmacologic modulation of basophil histamine release in asthmatic patients. 1996 Jun 1
14 8937731 The effect of selective phosphodiesterase 3 and 4 isoenzyme inhibitors and established anti-asthma drugs on inflammatory cell activation. 1996 Nov 1
15 9162320 [Evaluation of efficacy and tolerance of an antiasthmatic preparation--Ditec, consisting of low doses of disodium cromoglycate and fenoterol]. 1996 2
16 9499814 Hyperventilation during bronchial challenges in asthmatics: reproducibility and assessment of contributing factors. 1996 May 2
17 8099699 Effects of beta 2-receptor agonists on airway responsiveness. 1993 1
18 8104272 Regular inhaled salbutamol and airway responsiveness to allergen. 1993 Oct 2 2
19 1977787 Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol. 1990 Nov 2
20 3369752 The effect of adrenoceptor agonists and antagonists on histamine-induced wheal response in the skin of normal subjects and atopic patients. 1988 May 1
21 2446520 Fenoterol, a selective beta 2-adrenergic agonist, and inhibition of IgE-mediated basophil histamine release. 1987 Oct 1
22 2951806 Histamine-induced bronchial response after administration of placebo, salbutamol and a combination of a beta-2-adrenergic drug (fenoterol) with an anticholinergic agent (ipratropium bromide) in asymptomatic asthma patients. 1986 1
23 6203844 Inhibition of IgE-mediated histamine release from human basophils and mast cells by fenoterol. 1984 1
24 6197312 Effect of fenoterol on immunological release of leukotrienes and histamine from human lung in vitro: selective antagonism by beta-adrenoceptor antagonists. 1983 Nov 25 1
25 92803 Immunological release of histamine from human lung. I. Studies on the beta 2-sympathomimetic stimulator fenoterol. 1979 1
26 23051 [Metabolic and pharmacologic interactions on the bronchial tonus]. 1977 1